Eligibility criteria
Condition
None Volunteer
Sex
Females and Males
Age
18-75 years
Inclusion criteria
Show details
- Healthy
Exclusion criteria
Show details
- History of hypersensitivity to test compounds or excipients.
You are here
Taste Test of a New Formulation of Sildenafil (Revatio)
NCT00768573
Last updated on November 14, 2019
About this Study
taste of formulation
NCT00768573
Pfizer
Completed
Taste Test of a New Formulation of Sildenafil (Revatio)
NEED INFO?
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
| Descriptive Information | ||||
|---|---|---|---|---|
| Brief Title | Taste Test of a New Formulation of Sildenafil (Revatio) | |||
| Official Title | A Single-Blind Study In Healthy Adult Volunteers To Investigate The Palatability Of Different Oral Suspension Formulations Of Revatio® | |||
| Brief Summary | taste of formulation | |||
| Detailed Description | taste test None | |||
| Study Type | Observational | |||
| Study Design | Time Perspective: Prospective | |||
| Target Follow-Up Duration | Not Provided | |||
| Biospecimen | Not Provided | |||
| Sampling Method | Probability Sample | |||
| Study Population | Healthy volunteers | |||
| Condition | None Volunteer | |||
| Intervention | Drug: sildenafil Oral suspension of sildenafil. | |||
| Study Groups/Cohorts | 1. Taste test Not Specified Intervention: Drug: sildenafil | |||
| Publications * | Not Provided | |||
| * Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. | ||||
| Recruitment Information | ||||
| Recruitment Status | Completed | |||
| Actual Enrollment | 4 | |||
| Original Actual Enrollment | 8 | |||
| Actual Study Completion Date | January 2008 | |||
| Actual Primary Completion Date | January 2008 (Final data collection date for primary outcome measure) | |||
| Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria:
| |||
| Sex/Gender |
| |||
| Ages | 18 Years to 75 Years (Adult, Older Adult) | |||
| Accepts Healthy Volunteers | Yes | |||
| Contacts | Contact information is only displayed when the study is recruiting subjects | |||
| Listed Location Countries | United States | |||
| Removed Location Countries | ||||
| Administrative Information | ||||
| NCT Number | NCT00768573 | |||
| Other Study ID Numbers | A1481257 | |||
| Has Data Monitoring Committee | No | |||
| U.S. FDA-regulated Product | Not Provided | |||
| IPD Sharing Statement | Not Provided | |||
| Responsible Party | Pfizer | |||
| Study Sponsor | Pfizer | |||
| Collaborators | Not Provided | |||
| Investigators |
| |||
| PRS Account | Pfizer | |||
| Verification Date | April 2015 | |||
FOR MORE INFORMATION
Contact a representative by phone, email, or visiting the study website. Please see the references below:
BY PHONE
Pfizer Clinical Trials Contact Center
1-800-718-1021